Publications of C. Anish
All genres
Journal Article (24)
21.
Journal Article
52 (36), pp. 9524 - 9528 (2013)
Plague detection by anti-carbohydrate antibodies. Angewandte Chemie International Edition 22.
Journal Article
8 (11), pp. 2412 - 2422 (2013)
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania. ACS Chemical Biology 23.
Journal Article
49 (64), pp. 7159 - 7161 (2013)
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications 24.
Journal Article
135 (26), pp. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society Book Chapter (2)
25.
Book Chapter
Lepenies, B.). Springer Science+Business Media, New York (2015)
Generation of monoclonal antibodies against defined oligosaccharide antigens. In: Carbohydrate-Based Vaccines, pp. 57 - 80 (Ed. 26.
Book Chapter
Carbohydrate Vaccines. In: Biotherapeutics: Recent Development using Chemical and Molecular Biology, pp. 68 - 104 (Eds. Jones, L. H.; McKnight, A. J.). RSC, Cambridge (2013)
Meeting Abstract (3)
27.
Meeting Abstract
70 (S 01), P489. 57. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Leipzig, March 02, 2016 - March 05, 2016. (2016)
Passive Immunisierung mit dem monoklonalen Antikörper 1H8 schützt Mäuse vor pneumogener Sepsis. In Pneumologie, 28.
Meeting Abstract
24 (11), p. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, November 16, 2014 - November 19, 2014. Oxford University Press, Oxford (2014)
Deciphering glycan-antibody interactions: towards a carbohydrate-based vaccine against Clostridium difficile. In Glycobiology, 29.
Meeting Abstract
24 (11), p. 1122 - 1122. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, November 16, 2014 - November 19, 2014. Oxford University Press, Oxford (2014)
Antigenic potential of a highly conserved lipopolysaccharide inner core structure defined by synthetic approach. In Glycobiology, Patent (11)
30.
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)
31.
Patent
Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
32.
Patent
Vaccine against carbapenem-resistant klebsiella pneumoniae. EP3274358 (2016)
33.
Patent
Vaccines against Streptococcus pneumoniae serotype 4. EP3230297 (2016)
34.
Patent
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
35.
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 8. (2016)
36.
Patent
Synthetic vaccines against Streptococcus pneumoniae type 1. (2015)
37.
Patent
Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis. EP2766024 A1 (2014)
38.
Patent
Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis. (2013)
39.
Patent
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)
40.
Patent
Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3. WO2015040140 (2012)